MBRX ▲ +3.3% - Moleculin Biotech, Inc.
$MBRX - Moleculin Secures Australian Patent for Annamycin Formulation Technology
12-NOV-2026 08:37 AM ET
Share this post
More filings for $MBRX
MBRX ▲ +0.9% - Moleculin Biotech, Inc.Nov 10, 2026MBRX ▲ +2.3% - Moleculin Biotech, Inc.Nov 4, 2026MBRX ▼ -0.2% - Moleculin Biotech, Inc.Oct 30, 2026MBRX ▼ -95.0% - Moleculin Biotech, Inc.Oct 20, 2026MBRX ▼ -10.8% - Moleculin Biotech, Inc.Oct 16, 2026MBRX ▼ -1.8% - Moleculin Biotech, Inc.Sep 29, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment